The global tissue banking market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.65% during 2023-2028.
Tissue banking refers to the process of collecting, preparing, and preserving transplantable human tissues for potential therapeutic uses. The tissues obtained are utilized in healing and replacing the affected or lost tissues of the patients. They are also used to repair damaged heart muscles, treat spinal cord injuries, and heal skin from severe burns. At present, advancements in clinical trials and biomedical research are contributing to the demand for tissue preservation and banking across the globe.
Tissue Banking Market Trends:
The coronavirus disease (COVID-19) pandemic has caused several deaths globally. As a result, researchers are relying on tissue banks to collect tissue specimens, understand cellular responses and the biological impact of infection and identify new therapeutic interventions and prevention strategies. Apart from this, the growing diagnosis of new diseases is escalating the demand for tissue banking in drug discovery. Moreover, the increasing prevalence of chronic diseases is positively influencing the adoption of tissue banks for the transplantation of bones, tendons, corneas, heart valves, and skin. Additionally, the rising geriatric population, in confluence with the growing number of individuals undergoing surgical interventions, is increasing the use of human tissue allografts across the globe. These tissues are used to repair limbs, relieve pain, and improve patients' life quality. Furthermore, the emerging trend of cosmetic surgeries on account of inflating disposable income and the growing consciousness among individuals about physical appearances is driving the market. Besides this, tissue banks can reduce the risk of bacterial and fungal contamination of tissues by using aseptic surgical techniques, equipment and supplies while processing and storing the tissue from the donor. This, in confluence with rising concerns about cross-infection, is creating a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global tissue banking market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and tissue type.
Breakup by Product:
Equipment
Cryopreservation Equipment
Thawing Equipment
Quality Control Equipment
Others
Media and Consumables
Breakup by Application:
Therapeutics
Medical Research
Others
Breakup by Tissue Type:
Cardiovascular Tissue
Lung Tissue
Kidney Tissue
Pancreas Tissue
Liver Tissue
Eye Tissue
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., and VWR International LLC (Avantor Inc).
Report Coverage:
Report Features
Details
Base Year of the Analysis
2022
Historical Period
2017-2022
Forecast Period
2023-2028
Units
US$ Billion
Segment Coverage
Product, Application, Tissue Type, Region
Region Covered
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered
AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., and VWR International LLC (Avantor Inc)
Customization Scope
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
10-12 Weeks
Delivery Format
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global tissue banking market was valued at US$ 1.6 Billion in 2022.
We expect the global tissue banking market to exhibit a CAGR of 11.65% during 2023-2028.
The high prevalence of several chronic diseases, along with the increasing adoption of tissue banks
for the transplantation of bones, tendons, corneas, etc., is primarily driving the global tissue banking
market.
The sudden outbreak of the COVID-19 pandemic has led to the rising utilization of tissue banking to
collect tissue specimens and study the biological impact of the SARS-CoV-2 virus, to identify new
therapeutic interventions and prevention strategies.
Based on the product, the global tissue banking market can be categorized into equipment and
media and consumables, where equipment exhibits clear dominance in the market.
Based on the application, the global tissue banking market has been segmented into therapeutics,
medical research, and others. Currently, therapeutics represent the largest market share.
Based on the tissue type, the global tissue banking market can be bifurcated into cardiovascular
tissue, lung tissue, kidney tissue, pancreas tissue, liver tissue, eye tissue, and others. Among these,
cardiovascular tissue currently accounts for the majority of the total market share.
On a regional level, the market has been classified into North America, Europe, Asia-Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global tissue banking market include AMS Biotechnology, Beckman
Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks
Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-
Wharton, Thermo Fisher Scientific Inc., and VWR International LLC (Avantor Inc).
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
This site uses cookies (including third-party cookies) to record user’s preferences which help us to enhance our services. For further information review our Privacy Policy.
This site uses cookies to improve user experience.Privacy Policy.